News 2020-02-02
Announcement
All possible measures are taken to effectively safeguard the safety and health of all Porton employees in China, especially for our employees in Changshou Site. We are now concentrating resources to ensure that all ongoing projects are carried out in an orderly manner.
Porton Pharma Solutions Ltd.
Feb. 2nd, 2020
Nothing is Impossible For A Willing Heart!
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes

News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.